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N-myc downstream-regulated gene 1 (NDRG1) is a tumour suppressor
involved in vesicular trafficking and stress response. NDRG1 participates
in peripheral nerve myelination, and mutations in the NDRG1 gene lead to
Charcot-Marie-Tooth neuropathy. The 43-kDa NDRG1 is considered as
an inactive member of the a/b hydrolase superfamily. In addition to a cen-
tral a/b hydrolase fold domain, NDRG1 consists of a short N terminus
and a C-terminal region with three 10-residue repeats. We determined the
crystal structure of the a/b hydrolase domain of human NDRG1 and char-
acterised the structure and dynamics of full-length NDRG1. The structure
of the a/b hydrolase domain resembles the canonical a/b hydrolase fold
with a central b sheet surrounded by a helices. Small-angle X-ray scattering
and CD spectroscopy indicated a variable conformation for the N- and C-
terminal regions. NDRG1 binds to various types of lipid vesicles, and the
conformation of the C-terminal region is modulated upon lipid interaction.
Intriguingly, NDRG1 interacts with metal ions, such as nickel, but is prone
to aggregation in their presence. Our results uncover the structural and
dynamic features of NDRG1, as well as elucidate its interactions with met-
als and lipids, and encourage studies to identify a putative hydrolase activ-
ity of NDRG1.
Databases
The coordinates and structure factors for the crystal structure of human NDRG1 were depos-
ited to PDB (PDB ID: 6ZMM).
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Introduction
The myelin sheath plays a crucial role in increasing the
speed of action potentials along neuronal axons in the
vertebrate nervous system. Myelin is produced by
oligodendrocytes in the central nervous system (CNS)
and Schwann cells in the peripheral nervous system
(PNS). One of the major characteristics distinguishing
myelin from other biological membranes is its high
lipid-to-protein ratio: isolated myelin contains at least
70% lipid [1]. The importance of the insulative nature
of myelin is highlighted by severe neurological defects
caused by myelin loss (demyelination) as a conse-
quence of disease, such as multiple sclerosis, Guillain-
Barre syndrome or Charcot-Marie-Tooth disease
(CMT).
Charcot-Marie-Tooth disease is the most common
hereditary demyelinating neuropathy affecting periph-
eral nerves, and it can be divided into subtypes based
on electrodiagnostic findings and inheritance patterns
[2,3]. Several homozygous mutations in N-myc down-
stream-regulated gene 1 (NDRG1) cause CMT type
4D, which was first identified in the Gypsy community
of Lom in Bulgaria [4] and later described in several
other European countries [5,6] as well as in China
[7,8]. Neuropathological findings in CMT4D point
towards Schwann cell dysfunction indicated by
demyelination/remyelination and hypomyelination,
onion bulb formation and accumulation of pleomor-
phic material in the adaxonal Schwann cell cytoplasm
[9–12]. Axonal involvement is evident by severe, pro-
gressive axonal loss and the presence of curvilinear
intra-axonal inclusions [10,12]. The founding mutation
R148X also affects CNS myelin [13,14]. In addition to
humans, a neuropathy with similar symptoms caused
by mutations in NDRG1 has been observed in certain
dog breeds, such as Greyhounds [15] and Alaskan
Malamutes [16].
Neuropathological findings suggest that NDRG1
plays a role in the formation and maintenance of the
myelin sheaths in peripheral nerves [17]. In vertebrates,
NDRG1 is largely expressed in oligodendrocytes and
Schwann cells [18–21]. In the PNS, NDRG1 is a target
of the phosphatidylinositol-3-kinase (PI3K)/protein
kinase B (AKT)/mammalian target of rapamycin
(mTOR) pathway, being phosphorylated in the C ter-
minus by AKT1 in developing nerves [20] and predom-
inantly by serum and glucocorticoid-regulated kinase 1
(SGK1) in adults [20,22]. In murine and canine tissues,
phosphorylated NDRG1 is exclusively localised in the
abaxonal cytoplasm of the myelinating Schwann cells,
while total NDRG1 is present throughout the cyto-
plasm [20,21].
The human NDRG1 (also known as CAP43, DRG1,
NDR1, PROXY1, RIT42, RTP and TDD5) is mapped
to chromosome 8q24.22 and codes for a 43-kDa pro-
tein [4,23]. NDRG1 forms, together with NDRG2,
NDRG3 and NDRG4, a protein family, which shares
53–65% sequence identity, the highest identity laying
in the area of an a/b hydrolase motif (Fig. 1) [24].
However, NDRG proteins seem to lack catalytic activ-
ity [25,26], although the a/b hydrolase domain of
NDRG1 was recently suggested to bind fatty acids
[27]. Crystal structures of the a/b hydrolase domain of
human NDRG2 isoform 2 (residues 23–304) [26] and
human NDRG3 (residues 29–320) [28] show the
absence of a canonical catalytic triad and blockage of
a possible substrate-binding cavity by helices a7 and
a10. Phylogenetically, NDRG1 and NDRG3 belong to
one subfamily, while NDRG2 and NDRG4 belong to
another [24]. NDRG1 contains three tandem repeats
of 10 amino acids (GTRSRSHTSE) in its C terminus
[23], which are absent in the other family members
(Fig. 1). NDRG1 has high evolutionary conservation
from plants to humans [29], which suggests an impor-
tant biological role (Fig. 2). The other NDRG family
members have not been linked to demyelinating neu-
ropathies [30], although all human CMT4D-related
mutations are located in the a/b hydrolase domain of
NDRG1.
The physiological functions of NDRG1 have
remained ambiguous. In humans, NDRG1 mRNA is
found in most organ systems, and the protein is
mainly localised in the cytoplasm; however, the protein
can also be found in the nucleus, mitochondria or
membranes, depending on the tissue type [18]. In
Fig. 1. Sequence alignment of human NDRG isoforms. The secondary structure of NDRG1 is shown above the sequence alignment
(predicted helices missing from the crystal structure with dashed lines), and the a/b hydrolase fold of NDRG1 is marked with a cyan stroke
under the alignment. Identical and similar residues are highlighted in red and yellow, respectively. Potential catalytic residues of NDRG1 are
marked with red triangles, and putative metal-binding residues with pink triangles. SGK1-dependent phosphorylation sites, the SUMOylation
site and a predicted site for proteolytic cleavage are marked with green circles, a grey circle and a black triangle, respectively. Amino acid
substitutions causing CMT4D are marked with black asterisks, and the open blue box indicates the triple decapeptide repeat of NDRG1.
Sequences were aligned with T-Coffee [97] and visualised using ESPript [98]. UniProtKB accession numbers were as follows: NDRG1
(Q92597-1), NDRG2b (Q9UN36-2), NDRG3 (Q9UGV2-1), NDRG4 (Q9ULP0-1).
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Fig. 3. NDRG1 contains a central globular a/b hydrolase fold, an N-terminal 30-residue region and a C-terminal region containing three 10-
residue repeats. (A) Schematic view of NDRG1. The a/b hydrolase fold, C-terminal repeat, phosphorylation (P), SUMOylation (S) and
predicted proteolytic cleavage (arrow between C49 and G50) sites as well as residues mutated in CMT4D (asterisk) have been marked. The
constructs used in this study have been illustrated below. (B) SEC-MALS curves of NDRG1fl (black), NDRG11–319 (blue), NDRG122–319
(green) and NDRG131–319 (red). (C) An asymmetric unit contains two NDRG1 molecules; the cap region is marked with beige and the a/b
hydrolase fold in blue. Panels C–G were prepared using PyMOL (https://pymol.org/2/). (D) Transparent electrostatic surface shown with two
views. (E) Superimposition of NDRG1 (blue) NDRG2b (brown) and NDRG3 (green) a/b hydrolase domains indicates minor differences in
overall structure. (F) The canonical catalytic site is not present in NDRG1, but potential catalytic amino acids (Asp64 and His194) are located
in a nearly equivalent position in the structure. (G) The catalytic site of Bacillus subtilis stress–response regulator, RsbQ (orange),
superimposed with NDRG1 (blue).
Fig. 2. Conservation of NDRG1 between species. Potential catalytic residues (red triangles), putative metal-binding residues (pink triangles),
phosphorylation sites (green circles), a SUMOylation site (grey circle) and a predicted proteolytic cleavage site (black triangle) are marked as
in Fig. 1. The position of a disease-causing amino acid substitution in dogs (Alaskan Malamute) is marked with a blue asterisk, and the
homologous region with vertebrate IP3R is marked with an open black box. Sequences were aligned with T-Coffee [97] and visualised using
ESPript [98]. UniProtKB accession numbers were as follows: dog NDRG1 (L7V3M2-1), mouse NDRG1 (Q62433-1), zebrafish NDRG1
(Q6A3P5-1), fruit fly BcDNA : GH02439 (Q9Y164-1) and sunflower pollen-specific protein SF21 (Q23969-1).
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addition to phosphorylation, the N terminus of
NDRG1 can be post-translationally modified by prote-
olytic cleavage [31] and SUMOylation [32] (Fig. 3A).
The expression of NDRG1 can be altered by the
proto-oncogenes MYCN and MYC [33,34], p53 and
DNA damage [35], PTEN [36], androgens [37], DNA
methylation and histone acetylation [38] as well as
multiple compounds, such as cysteine, tunicamycin, 2-
mercaptoethanol [23] and retinoic acid [39]. In conse-
quence, NDRG1 functions at least in growth arrest
[35], cell differentiation [40], p53-mediated apoptosis
[41] and centrosome homeostasis [42,43]. NDRG1 is a
metastasis suppressor in prostate, breast and colon
cancers [44–46].
Hypoxia-inducible factor 1 (HIF-1) plays an impor-
tant role in cellular responses to hypoxia, including
regulation of genes involved in glycolysis, angiogenesis
and apoptosis. Nickel, cobalt and iron chelators mimic
hypoxia and can induce the expression of NDRG1 by
inducing and stabilising HIF-1 [47–50]. Nickel and
cobalt can substitute Fe2+ in enzymes acting in HIF-1
expression or stabilisation pathways, and iron chela-
tors can prevent the binding of oxygen to haeme
groups or degradation of HIF-1a and HIF-2a
[49,51,52]. Interestingly, NDRG1 might interact with
metals directly: a 30-amino acid peptide containing the
C-terminal repeats of NDRG1 (TRSRSHTSEG)3
binds nickel [53,54], copper [55], zinc [56], manganese
and cobalt [57].
From a PNS perspective, the most important role
of NDRG1 is in cellular trafficking: it interacts with
apolipoproteins [58] and cardiolipin [59], regulates
LDL receptor trafficking [60] and recycling of E-cad-
herin [59] and is involved in vesicle transport [61].
NDRG1 recruits on recycling endosomes in the
Golgi complex by binding to phosphatidylinositol 4-
phosphate (PI4P) and interacts with membrane-
bound RAB4a [59]. In addition, NDRG1 interacts
with Rab acceptor 1, which is required for lipid
transport and vesicle formation from the Golgi com-
plex [62]. In breast cancer cells, NDRG1 regulates
neutral lipid metabolism [27], and in cells infected
by hepatitis C virus, NDRG1 regulates lipid droplet
biogenesis [63]. In prostate cancer cells, NDRG1
interacts with the cell adhesion molecules E-cadherin
and b-catenin [64].
Despite extensive research on its physiological func-
tion, the structure and biochemical properties of
NDRG1 have remained uncharacterised. Thus, we
determined the crystal structure of the human NDRG1
a/b hydrolase domain and obtained information about
the structure and conformational dynamics of full-
length NDRG1 using small-angle X-ray scattering
(SAXS) and synchrotron radiation circular dichroism
(SRCD). Additionally, we used a combined approach
of CD, lipid cosedimentation, nanodifferential scan-
ning fluorimetry (nano-DSF) and isothermal titration
calorimetry (ITC) to study lipid and metal binding by
NDRG1 to better understand its role in lipid trans-
port, vesicular trafficking and stress response. NDRG1
interacts with various types of lipid membranes, and
the conformation of the C-terminal region is modu-
lated upon these interactions.
Results
NDRG1 is monomeric in solution
No experimental studies on the structural or biochemi-
cal characteristics of NDRG1 have been published.
Based on secondary structure predictions [65,66],
NDRG1 is composed of a short N-terminal region
(residues 1–30), a central a/b hydrolase domain includ-
ing a cap region (residues 31–310) and a flexible C-ter-
minal region consisting of three 10-amino acid
(GTRSRSHTSE) tandem repeats (residues 339–368;
Fig. 3A) not found in other NDRG family members
(Fig. 1).
To characterise NDRG1, we expressed and purified
full-length (fl) human NDRG1 (NDRG1fl) as well as
truncated forms containing residues 1–319 (NDRG11–319),
22–319 (NDRG122–319), 28–319 (NDRG128–319), 31–
319 (NDRG131–319) and 31–394 (NDRG131–394)
(Fig. 3A). Most NDRG1 constructs eluted as single
peaks in size-exclusion chromatography (SEC), while a
minor peak corresponding to a dimer was observed for
NDRG122–319 and NDRG128–319. NDRG131–394 was
unstable and degraded during purification. We
Table 1. SEC-MALS and SAXS parameters.
Constructs Calc. MW (kDa) SEC-MALS MW (kDa) Rg (A) Dmax (GNOM) (A) Dmax (EOM) (A) Porod V (A
3)
NDRG1fl 42.8 45.1 28.85  0.08 103 99 79 684
NDRG11–319 35.0 35.7 23.23  0.07 70 76 59 576
NDRG122–319 32.5 32.9 19.64  0.03 57.5 n.d. 54 045
NDRG128–319 32.1 n.d. 19.38  0.03 56.5 n.d. 51 292
NDRG131–319 31.7 33.4 20.41  0.02 61 n.d. 54 274
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determined the molecular weight of purified NDRG1
using multiangle light scattering (MALS) (Fig. 3B,
Table 1), and the observations fitted well to theoretical
monomeric molecular weights.
Nano-DSF is a label-free technique for measuring
protein stability utilising intrinsic Trp fluorescence of
proteins. We used nano-DSF to study the thermal sta-
bility of NDRG1. The melting temperature (Tm) of the
constructs varied from 56.5 to 60.5 °C (Table 2).
NDRG1 stability increased upon C-terminal trunca-
tion, while N-terminal truncation did not have a
strong effect.
Crystal structure of the central core domain
Despite comprehensive research on the cellular func-
tions and tumour suppressing characteristics of
NDRG1, no structural characterisation has been done.
We determined the crystal structure of the folded core
domain of human NDRG1 (residues 31–319) at 2.96-A
resolution (Fig. 3C, Table 3). The asymmetric unit in
the crystal contains two NDRG1 molecules (Fig. 3C).
The core of NDRG1 is composed of a canonical a/b
hydrolase fold with a central eight-stranded b sheet sur-
rounded by a helices and a cap domain. The cap domain
is formed by three helices as well as disordered regions,
and it covers the top of the a/b hydrolase fold (Fig. 3C).
We could not detect electron density for residues 170–
184 (putative a6 helix) and 197–201 (putative a8 helix)
in either of the NDRG1 chains. These residues are
located in the cap domain, and the absence of electron
density hints at flexibility of these parts in the NDRG1
structure. The electrostatic surface reveals a ring-shaped
negative zone perpendicular to the central b sheet on the
surface of NDRG1 (Fig. 3D).
The crystal structures of human NDRG2b and
NDRG3 have been determined [26,28]. The sequence
identity of the core domain of NDRG1 to NDRG3
and NDRG2b is 73% and 59%, respectively. The
overall fold of the a/b hydrolase and cap domains of
NDRG1 is similar to NDRG3 and NDRG2b, with
RMS deviations of 1.0 and 1.5 A, respectively
(Fig. 3E). In the crystal structure of NDRG2b, all
helices of the cap domain are visible, whereas in the
NDRG3 structure, the a6 helix is missing. The
NDRG1 cap domain resembles more the cap domain
of NDRG3 than NDRG2b.
NDRG1 belongs to the a/b hydrolase superfamily,
but based on sequence alignments, it lacks the canonical
a/b hydrolase catalytic triad [25]. However, a nearly
equivalent site in NDRG1 contains aspartate (Asp64)
and histidine (His194) residues, located at the end of
strand b3 and in the beginning of helix a7, respectively
(Fig. 3F–G). Aspartate and histidine are commonly
found in catalytic triads of a/b hydrolases. Unfortu-
nately, the electron density for the predicted a6 helix,
located on one side of this potential catalytic site, was
not clear enough to allow building the structure.
The interface between the two molecules in the asym-
metric unit was analysed using PISA [67]. The buried
area was ~ 890 A2, and the interactions between the
molecules included four hydrogen bonds and two salt
bridges. The complex formation significance score was
0.0, indicating that the interaction occurs due to crystal
packing and does not exist in solution.
Structure and flexibility of full-length NDRG1
To elucidate the structural properties of different
regions of NDRG1, we performed SRCD
Table 2. Melting temperatures (°C) for NDRG1
constructs  various ions, red text indicating increase of ≥ 0.5 °C
and blue text indicating decrease of ≥ 0.5 °C.
Constructs No additive Mg2+ Fe2+ Fe3+ Co2+ Ni2+
NDRG1fl 56.5 57.2 56.5 56.6 52.1 48.5
NDRG11–319 60.0 60.0 59.9 60.1 53.0 46.0
NDRG128–319 60.5 60.6 60.5 60.5 54.9 46.5
NDRG122–319 60.0 n.d. n.d. n.d. n.d. n.d.
NDRG131–319 58.8 n.d. n.d. n.d. n.d. n.d.
Table 3. Crystallographic data collection and refinement statistics.
Statistics for the highest resolution shell are shown in parentheses.
Human NDRG1 (PDB: 6ZMM)
Wavelength (A) 0.9762
Resolution range (A) 47.11–2.963 (3.069–2.963)
Space group P 43 21 2
Unit cell a, b, c (A) 108.57, 108.57, 119.33
Total reflections 64 600 (25 100)
Unique reflections 14 800 (1405)
Multiplicity 4.26 (4.39)
Completeness (%) 95.66 (93.04)
Mean I/r(I) 4.33 (1.42)
Wilson B-factor (A2) 63.7
Rmeas (%) 31.1 (125.6)
CC1/2 (%) 98.5 (75.5)
Rwork 0.2688 (0.4173)
Rfree 0.2948 (0.5360)
RMSD bonds (A) 0.002
RMSD bond angles (°) 0.58
Ramachandran favoured (%) 95.24
Ramachandran allowed (%) 4.35
Ramachandran outliers (%) 0.41
Rotamer outliers (%) 0.47
Clashscore 4.97
Average B-factor (A2) 65.4
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spectroscopy. All constructs gave SRCD spectra typi-
cal for a-helical proteins, with a maximum close to
194 nm and minima at 208 and 222 nm (Fig. 4A). In
the spectra of NDRG131–319 and NDRG131–394, these
features were slightly weaker, indicating a reduced sec-
ondary structure content. In contrast, the fragments
lacking the C-terminal region showed more pro-
nounced spectral features, pointing towards a disor-
dered nature of the C-terminal region (Fig. 4A). The
deconvolution of the SRCD spectra of NDRG1fl,
NDRG11–319 and NDRG131–319 predicted an a-helical
content of 28.9%, 30.9% and 29.1%, respectively,
whereas b sheets were predicted to cover 16.3%,
13.1% and 16.2% of the fragments. The calculated
spectra for residues 1–30 indicate partial folding of the
N-terminal region, while the calculated spectrum for
the C terminus is typical for a random coil with a clear
peak minimum at 198 nm.
Small-angle X-ray scattering is powerful technique
to study proteins with flexible regions, such as
NDRG1. We collected SEC-SAXS data for NDRG1
constructs (Fig. 4B). All constructs behaved well in
Fig. 4. NDRG1 has partially folded N-terminal region, a central globular core domain and disordered C terminus. (A) SRCD spectra for NDRG1
constructs and calculated spectra of the N and C terminus. (B) Scattering patterns for NDRG1 fragments: NDRG1fl (black), NDRG11–319 (blue),
NDRG122–319 (green), NDRG128–319 (purple), NDRG131–319 (red). (C) Linear Guinier regions of NDRG1 constructs confirm the good quality of SAXS
data. (D) Distance distribution functions indicate highly elongated confirmation for NDRG1fl (black), while NDRG122–319 (green), NDRG128–319
(purple) are the most compact NDRG1 constructs. (E) Dimensionless Kratky plot suggests a globular shape of constructs containing residues
NDRG122–319, NDRG128–319 and NDRG131–319 whereas NDRG11–319 is slightly less globular and rigid and NDRG1fl the most flexible. The black
cross indicates the theoretical peak position for a rigid globular protein. (F) Ab initiomodels for NDRG1fl (grey), NDRG11–319 (blue) and NDRG131–
319 (red). Panels F, H and I were prepared using PYMOL. (G) Dmax distributions from EOM analysis for NDRG1fl and NDRG11–319 indicate flexible but
more compact than random coil peptide for both N- and C-terminal regions; solid lines represent the ensembles for NDRG1fl (black) and NDRG11–
319 (blue) and dashed lines theoretical distribution for random coils. EOM conformations suggest N terminus may fold on the side of the core
domain observed in one of the conformations of NDRG11–319 (H). EOM suggests rather flexible and disordered nature of the C terminus observed
in the pool of conformations of NDRG1fl (I).
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SAXS and gave linear Guinier regions (Fig. 4C). The
scattering patterns (Fig. 4B), Rg and Dmax of NDRG1
core fragments illustrate a globular shape (Dmax 57.5,
56.5 and 61.0 A for NDRG122–319, NDRG128–319 and
NDRG131–319, respectively), while NDRG11–319 adopts
slightly more extended conformation (Dmax 70 A), and
NDRG1fl is remarkably more elongated, with a Dmax
of 103 A (Table 1). None of the fragments showed
signs of a second distinct globular domain in the pair
distance distribution (Fig. 4D). Based on the dimen-
sionless Kratky plot, NDRG1fl has the highest flexibil-
ity, whereas NDRG11–319 is more flexible compared to
the most globular core fragments (Fig. 4E). Thus, the
N- and C-terminal regions are flexible additions to the
rigid, globular core domain.
Keeping in mind the flexible nature of the longer
NDRG1 variants, we built ab initio chain-like models
to illustrate the average shape and dimensions of
NDRG1 in solution. The core domain is compact and
globular, resembling the crystal structure. The envel-
opes of the NDRG11–319 and NDRG1fl constructs
(v2 = 1.0–1.1) have an extension on one side of the
globular domain (Fig. 4F).
The ensemble optimisation method (EOM) has been
developed for flexible and intrinsically disordered pro-
teins, allowing to generate an ensemble of conforma-
tions, which together reproduce the measured SAXS
pattern [68]. EOM gives insight into flexibility and par-
tially folded and dynamic regions in proteins. Utilising
the crystal structure of the core domain and the scatter-
ing profile of NDRG11–319, an ensemble of N-terminal
conformations was modelled. EOM resulted in two con-
formations (v2 = 1.1); a compact conformation (Dmax
60 A), with the N-terminal region folded on the core
domain, comprises ~ 55% of the particles. In the second
conformation, the N terminus is more elongated (Dmax
89 A), disordered and flexible (Fig. 4G,H).
Similarly, we analysed the conformation ensemble of
the NDRG1fl in solution. The obtained ensemble of four
conformations fit well to the experimental data
(v2 = 1.0). Within the NDRG1fl ensemble, the N-termi-
nal region occasionally folds onto the core domain, while
the C terminus is disordered (Fig. 4I). The C-terminal
region is apparently less flexible than a random coil pep-
tide, and it can also adopt a compact conformation
(Fig. 4I). The above results point towards a dynamic nat-
ure of both the N and C termini of NDRG1.
NDRG1 interacts with nickel and other metal
ions
Nano-DSF can be utilised for studying protein stabil-
ity in the presence of various additives, such as metal
ions or protein ligands. We investigated the effects of
metal ions on the thermal stability of NDRG1fl,
NDRG11–319 and NDRG128–319. Fifty micromolar
Fe2+, Fe3+, Mg2+ did not affect the Tm of any con-
struct while Co2+ and Ni2+ destabilised all variants
(Fig. 5A, Table 2). The effect was more pronounced
with NDRG11–319 and NDRG128–319 than with
NDRG1fl. Zn
2+ caused precipitation of NDRG1fl
immediately upon addition.
To study the effect of metals on the secondary struc-
ture content of NDRG1fl, we performed CD spec-
troscopy. The a-helical content of NDRG1fl increased
at low concentrations of Ni2+ or Fe2+ (Fig. 5B,C); in
the presence of 50 µM Ni2+ and Fe2+, the a-helical con-
tent increased from 22% to 25–26%. On the other
hand, in the presence of Co2+ NDRG1 lost 10% of its
a-helical content (Fig. 5D).
NDRG1 expression is induced by nickel and cobalt
[69] as well as upon iron chelation [49]. The C-terminal
region of NDRG1 has been reported to directly inter-
act with nickel [53,54], copper [55], zinc [56], man-
ganese and cobalt [57]. The nickel-binding capacity of
NDRG1fl, NDRG11–319 and NDRG128–319 was investi-
gated by ITC. The binding affinity (Kd) of all con-
structs is in the same range (Fig. 5E,F, Table 4). The
stoichiometry was close to 1 and was fixed to 1 for all
constructs since the concentrations were too low for
accurately refining all parameters. Both truncated con-
structs showed slightly higher affinity than NDRG1fl,
indicating involvement of the core domain in nickel
binding.
NDRG1 folds upon lipid vesicle binding
NDRG1 is involved in several cellular lipid-related
phenomena, such as vesicle and receptor transport
[60,61] and lipid droplet biogenesis [63]. Hence, we
investigated the interaction of NDRG1 with lipid
membranes using unilamellar vesicles as a model sys-
tem. In lipid cosedimentation assays, more than half
of NDRG1fl cosedimented with 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) vesicles, while in
the absence of lipids, the protein remained in the
supernatant. These results indicate the binding of
NDRG1fl to POPC vesicles (Fig. 6A). Variants lacking
the C terminus (NDRG11–319) or containing only the
core domain (NDRG128–319) showed less binding to
POPC vesicles (Fig. 6A).
The interaction of NDRG1 with 1,2-dimyristoyl-sn-
glycero-3-phosphocholine : 1,2-dimyristoyl-sn-glycero-
3-phosphoglycerol (DMPC : DMPG) vesicles, in
which the membrane surface has a negative charge,
was explored. DMPC : DMPG (1 : 1) vesicles pulled
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down ~ 50% of NDRG1fl, while only ~ 35% cosedi-
mented with the less negatively charged
DMPC : DMPG (9 : 1) vesicles. In contrast, both
NDRG11–319 and NDRG128–319 showed an overall
reduced binding affinity towards DMPC : DMPG
vesicles (Fig. 6B).
To study whether the conformation of the flexible N-
and C-terminal regions was affected by binding to POPC
or DMPC : DMPG vesicles, we carried out CD spec-
troscopy for NDRG1fl and NDRG11–319 in the presence
and absence of vesicles. With POPC, a spectral change
was observed with both constructs, but the change was
more prominent for NDRG1fl (Fig. 6C), indicating that
the C-terminal region may enhance POPC binding but is
not crucial for the interaction. DMPC : DMPG (1 : 1)
induced a clear change in the CD spectrum of NDRG1fl
(Fig. 6C, left panel), whereas only a minor change was
seen for NDRG11–319 (Fig. 6C, right panel).
DMPC : DPMG (9 : 1) did not induce a conformational
change in NDRG1fl. Based on these data, the flexible C-
terminal region is involved in NDRG1 binding to POPC
and DMPC : DMPG (1 : 1) vesicles, and the C terminus
adopts a more a-helical conformation upon binding to
vesicles. The conformation of the N terminus, in con-
trast, does not change in the presence of POPC or
DMPC : DMPG vesicles, and this region may not be
involved in membrane binding.
NDRG1 participates in phosphatidylinositol phos-
phate (PIP)-related cellular processes, such as mem-
brane trafficking [59] and cell signalling [70]. NDRG1
was reported to bind to PI4P [59], but no information
about direct interactions between NDRG1 and other
PIPs exists. We studied the effect of PIPs on NDRG1
membrane binding by incorporating various PIPs,
PIP2s and PIP3 into POPC vesicles and following their
effects on lipid cosedimentation of NDRG1. Fifty to
sixty percent of NDRG1fl was pulled down to the pel-
let regardless of the type of PIP, and no specificity
towards any PIP was observed (Fig. 7A). NDRG11–
319, in contrast, showed marginally reduced binding to
all PIP-containing vesicles (Fig. 7B), while the central
core domain was not affected (Fig. 7C).
CD spectroscopy was utilised to reveal the influence
of PIP-containing vesicles on the conformation of
NDRG1fl and NDRG11–319. PI4P, PI(3,5)P2, PI(4,5)P2
and PI(3,4,5)P3 gave stronger minima at 208 and
222 nm compared to POPC control vesicles, whereas
PI5P and PI(3,4)P2 reduced the secondary structure
content of NDRG1fl (Fig. 7D). The CD spectra of
NDRG11–319 were not affected by PIPs (Fig. 7E).
As NDRG1 interacted with Ni2+, we wanted to
explore whether lipids and metals compete or cooper-
ate in NDRG1 binding. In addition to Ni2+, the effects
of Fe2+, Zn2+ and Mg2+ on POPC binding were inves-
tigated. Ni2+ slightly increased the cosedimentation
with POPC vesicles, but none of the ions reduced the
POPC binding of NDRG1fl (Fig. 7F), demonstrating
that the lipid- and metal-binding sites in NDRG1 do
not compete with each other.
Discussion
NDRG1 is involved in several pathological conditions,
such as CMT4D [4] and various cancers [36,38,46]. Its
function as a tumour suppressor has been widely
explored, but the structural and dynamical features of
the NDRG1 molecule have remained obscure. In this
study, we determined the crystal structure of the a/b
hydrolase domain of human NDRG1 and studied the
structural and biochemical properties of full-length
NDRG1, including interactions with lipids and metal
ions.
a/b hydrolase fold of NDRG1
We solved the crystal structure of construct
NDRG131–319, comprising the a/b hydrolase domain
of NDRG1. NDRG1 has two molecules in the asym-
metric unit, whereas the asymmetric unit of NDRG3
contains six molecules, and NDRG3 dimerisation
Table 4. Thermodynamic parameters of Ni2+ binding determined
by ITC.
Parameters NDRG1fl NDRG11–319 NDRG128–319
Ka 9 10
3 (M1) 9.41  0.39 29.2  2.03 30.6  2.24
N 1 1 1
DH (kcalmol1) 1.37  3.67 5.25  0.17 2.03  0.65
DS (calmol1deg1) 27.9 2.83 13.7
Kd (µM) 106 34.3 32.7
Fig. 5. NDRG1 is metal-sensitive and interacts with nickel. (A) DSF curves of NDRG1fl alone (black) and in the presence of Co
2+ (yellow),
Ni2+ (blue), Fe2+ (purple), Fe3+ (red) and Mg2+ (green) show major effects of Ni2+ and Co2+ on protein stability. The CD spectra for NDRG1fl
in the presence of 0, 5, 10, 20 and 50 µM NiSO4 (blue) (B), FeSO4 (purple) (C) or CoCl2 (yellow) (D). E ITC titration of NiSO4 to NDRG1fl
gives a Kd of 106 µM, whereas NDRG11–319 shows slightly higher affinity towards Ni
2+ (F).
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takes place in solution (64). Based on SEC-MALS
(Fig. 3B) and structural analyses, NDRG1 is a mono-
mer similarly to NDRG2b [26], illustrating a mono-
meric biological unit for these proteins.
The NDRG1 crystal structure lacks electron density
for helices a6 and a8. Flexible, disordered regions in
proteins often play a fundamental role in protein–pro-
tein interactions or ligand binding. Such regions may
fold and rigidify upon binding to a substrate or an
Fig. 6. NDRG1 interacts with lipid vesicles. (A) Representative SDS/PAGE analysis of POPC vesicle cosedimentation assay. S, supernatant;
P, pellet. Pellet fractions are shown as black circles and supernatant as red triangles, single data points (n = 6) as well as the average and
SD are shown (right panel). Sixty percent of NDRG1fl cosedimented with electrically neutral POPC vesicles whereas ~ 40% of NDRG11–319
and < 40% of NDRG128–319 fragment was pelleted. (B) A representative SDS/PAGE analysis of DMPC : DMPG vesicle cosedimentation
assay. N = 3 per sample. Fifty percent of NDRG1fl was pelleted with negatively charged DMPC : DMPG (1 : 1) vesicles, and the protein
pelleted slightly less when less negatively charged DMPC : DMPG (9 : 1) vesicles were used. NDRG11–319 and NDRG128–319 remained
mainly in the supernatant. (C) CD spectra for NDRG1fl (black) in the presence of POPC (red), DMPC : DMPG (1 : 1) (green) and (9 : 1)
vesicles (orange; left panel) indicate the NDRG1fl adopts more secondary structure in the presence of POPC and DMPC : DMPG (1 : 1).
The same phenomenon is not observed with DMPC : DMPG (9 : 1) vesicles with NDRG11–319 (right panel).
12 The FEBS Journal (2020) ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
Structure and function of NDRG1 V. Mustonen et al.
Fig. 7. NDRG1 interaction with PIPs and potential competition between lipid vesicles and nickel binding. (A) A representative SDS/PAGE
(left panel; S, supernatant; P, pellet) and a graph (right panel) showing the proportions of NDRG1fl in the pellet (black circles) and
supernatant (red triangles) fractions when various PIPs (10%) were incorporated into POPC vesicles. Individual data points as well as
average and SD are marked. PIPs did not remarkably alter the lipid vesicle binding of NDRG1fl. (B) The same assay with NDRG11–319
showed reduced binding to lipid vesicles containing PIPs. (C) NDRG128–319 showed stronger binding to PIP vesicles than NDRG11–319, but
still weaker than NDRG1fl. (D) CD spectra of NDRG1fl in the presence of PIP-POPC lipid vesicles. PI4P, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3
induced NDRG1fl to adopt more a helical conformation than POPC alone. (E) With NDRG11–319, the same phenomenon was not seen in
SRCD measurements. F POPC vesicle cosedimentation of NDRG1fl in the absence and presence of 50 µM NiSO4. As a control, the
sedimentation of NDRG1fl was carried out in the presence of NiSO4 alone. N = 3 per sample for cosedimentation analyses.
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interaction partner. To shed light on whether this hap-
pens in the NDRG1 cap domain, further studies will
be required with interaction partners or ligands. For
NDRG2, the a6 helix is important for interaction with
b-catenin [26]. Helix a6 is highly conserved among
NDRGs (Fig. 1), but structural features are different
[28]. How these differences affect b-catenin binding
remains unclear.
Based on sequence alignments, NDRG1 has been
predicted to be an inactive member of the a/b hydro-
lase family [25]. However, a region nearby the canoni-
cal catalytic site resembles a catalytic triad, having
histidine (His194) and aspartate (Asp64) in close prox-
imity (Fig. 3F). These two residues are conserved in
all human NDRGs (Fig. 1) as well as in all animal
NDRG1s and its homologs (Fig. 2). The third residue
of a possible triad is not visible in our structure; the
predicted a6 helix would be located nearby. Cys168,
which is located in the beginning of the flexible region
and points outwards in our structure, could in theory
make the catalytic triad complete. This Cys is found in
all vertebrate NDRG1s as well as in human NDRG3,
but in neither NDRG2 nor NDRG4 (Figs 1 and 2).
The flexible nature of the a6 helix potentially leaves
enough space for a putative substrate; however, in the
absence of known substrate we did not perform assays
for hydrolase activity. In an earlier study, human
NDRG2 did not show detectable hydrolase activity
towards q-nitrophenyl butyrate [26]. To conclude, the
NDRG1 crystal structure raises the possibility that the
site formed by His194, Asp64 and Cys168, close to the
canonical active site, could catalyse an as-of-yet
unknown enzymatic reaction.
On the other side of the NDRG1 a/b hydrolase
domain, close to the N terminus, there is a cluster of
histidine residues (His45, His69, His93) communed
with Thr47, Cys49 and Asp95 (Fig. 8A). Apart from
Cys49, these residues are conserved in human NDRG3
and vertebrate NDRG1s (Figs 1 and 2). Similar 3D
motifs are found in the active sites of metalloenzymes,
in which histidine residues often coordinate a metal
ion, such as Ni2+, Zn2+, Fe2+, Fe3+ or Mn2+ [71,72].
This histidine-rich site in NDRG1 closely resembles
the active site arrangement in 2,6-dichloro-p-hydro-
quinone 1,2-dioxygenase (PcpA), an oxidoreductase
from Sphingobium chlorophenolicum (Fig. 8B). Fe3+ is
bound to the active site of PcpA and involved in catal-
ysis [71]. We observed effects of several metal ions on
NDRG1 stability and conformation and confirmed
Ni2+ binding to the NDRG1 core domain. Nickel
competes with essential metals for ligands and binding
sites. Nickel induces DNA damage by binding to
DNA and nuclear proteins, as well as by catalysing
reactive oxygen species production, especially by inter-
fering with iron transport causing hypoxia [73].
NDRG1 is induced by a rise in free intracellular Ca2+
following nickel exposure, while, for example, zinc,
cobalt, copper, iron(II) and magnesium do not induce
its expression [47]. NDRG1 is suggested to act as a
nickel chelator through detoxification [53]. In addition,
the neurodegenerative disorders Alzheimer’s disease
and Parkinson’s disease are characterised by an
Fig. 8. Structural details of NDRG1. (A) The
histidine-rich region is located close to the
N terminus of the a/b hydrolase fold. Panels
A–D were prepared using PYMOL. (B) The
histidine-rich region resembles the active
site of PcpA oxidoreductase from
Sphingobium chlorophenolicum (pink)
superimposed with NDRG1 (blue).
Important residues are shown as sticks and
Fe3+ coordinated by PcpA sidechains as a
pink sphere. (C) A point mutation in Leu146
leads to CMT4D. Leu146 is located in the
middle of an a helix in the central part of
the a/b hydrolase fold. (D) R234Q mutation
has been found in CMT4D. Arg234 is in the
close proximity of the canonical active site
and forms a p–p stacking interaction with
Tyr231. (E) A schematic overview of
NDRG1 structural features and the
conformational changes.
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accumulation of metals, such as iron, copper, zinc,
manganese and calcium, and by increased levels of
oxidative stress, supporting the importance of essential
metal homeostasis in the brain [74,75]. NDRG1 inter-
acts with the DNA repair enzyme MGMT [76], while
MGMT can be epigenetically silenced by nickel [77].
The determination of the binding sites in the NDRG1
core domain, the effects of metal binding on NDRG1
function and putative enzyme activity and the affinity
of NDRG1 towards various metals remain to be clari-
fied in further studies.
The NDRG1 N terminus is dynamic
The N-terminal region is rather conserved between
NDRG1 and NDRG3 (Fig. 1). Our structural analysis,
based on SRCD and SAXS, shows the N terminus may
adopt a compact a-helical confirmation and fold on the
side of the a/b hydrolase domain. The N terminus con-
tains several hydrophobic residues, which are unlikely to
be exposed. This endorses a model with the N terminus
folding onto the a/b hydrolase domain. The fact that we
were unable to crystallise NDRG11–319 supports the
results of the EOM analysis, in which two N-terminal
conformations were obtained (Fig. 4H). These confor-
mations could, for example, allow an autoregulatory
mechanism of NDRG1 function. Such cases have been
observed in phenylalanine hydroxylases, which contain
an autoinhibitory N-terminal sequence reaching into the
active site. Part of the N-terminal residues are mobile,
but the mobility decreases upon the addition of pheny-
lalanine [78]. Similarly, Candida rugosa lipase has an N-
terminal lid with two conformations: open with the
hydrophobic face directed towards the active site and
closed with the hydrophobic face buried against the core,
covering the active site [79].
In lipid cosedimentation assays, NDRG11–319 showed
remarkably reduced binding to all lipid vesicles with a
negative charge. NDRG11–319 had higher affinity
towards neutral lipid vesicles, which could allow partici-
pation in neutral lipid homeostasis, as observed in studies
on NDRG1 in breast cancer cells [27]. Lipid binding had
no effect on the folding of the N-terminal region, exclud-
ing the possibility that the conformation of the N termi-
nus is directly regulated by the binding to lipid
membranes.
C-terminal region may fold upon interactions and
is responsible for binding to various PIPs
Human NDRG1 contains a C-terminal region not found
in other NDRGs. This 75-residue region in human
NDRG1 contains three 10-residue repeats, but the
number of repeats varies between species (Fig. 1). Each
repeat includes a histidine residue, which can coordinate
a nickel, copper, zinc, manganese or cobalt ion [53,55–
57]. We revealed that the NDRG1 C terminus is dynamic
and mainly disordered but may fold upon binding to
lipid vesicles or metal ions, such as Ni2+ or Fe2+. Surpris-
ingly, in ITC experiments, NDRG1fl had no increased
affinity towards Ni2+ compared with NDRG11–319 or
NDRG128–319. This supports the hypothesis of an addi-
tional metal-binding site in the a/b hydrolase domain of
NDRG1.
The C-terminal region is important for NDRG1
membrane interactions. This region is mainly composed
of charged residues, and only a few hydrophobic resi-
dues exist. The amino acid composition suggests the C
terminus is not embedded into a lipid bilayer, but
NDRG1 interaction with membranes mainly occurs via
lipid head groups. Negatively charged lipids resulted in
a conformational change in the C terminus. All PIPs
have a negatively charged head group, but interestingly,
only some of them induced a conformational change in
NDRG1. We could not see clear differences between
various PIPs in lipid cosedimentation, but in CD spec-
troscopy, PI4P, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3 had
a positive effect on folding. Similarly, recent studies on
the myelin protein P2 indicated that while headgroup
negative charge is important for binding to a membrane
surface, the lipid composition has an effect on binding-
related conformational changes and possibly function
[80]. Previously, using an overlay assay, NDRG1 was
reported to bind PI4P but not PI(4,5)P2 or PI(3,4,5)P3
[59]. PI4P is an abundant component of trans-Golgi
membranes and involved in vesicular transport to the
plasma membrane. By contrast, the less abundant PI
(3,5)P2 participates in endosomal vesicle trafficking. A
reduced amount of PI(3,5)P2 in cells leads to neuronal
symptoms in the CNS and PNS [81]. Intriguingly, muta-
tions in Fig 4, encoding a polyphosphoinositide phos-
phatase involved in synthesis and turnover of PI(3,5)P2,
result in CMT type 4J [82]. Furthermore, mutations in
MTMR2, encoding a phosphatase dephosphorylating
PI3P and PI(3,5)P2, result in CMT type 4B1 [83]. These
findings indicate that CMT subtypes linked to NDRG1,
Fig 4 and MTMR2 mutations may have a common
defect in endosome-to-lysosome trafficking, as has been
suggested earlier [84]. In fact, NDRG1 containing the
CMT4D founding mutation R148X is unstable and
unable to facilitate endosomal recycling [60].
The NDRG1 homolog in the sun flower (SF21) shows
similarity to the ligand binding region of vertebrate inosi-
tol 1,4,5-triphosphate receptor (IP3R), and the same
region is present in human (residues 179–279) and mur-
ine NDRG1 (Fig. 2) [29]. IP3R is an intracellular channel
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that mediates Ca2+ release from the endoplasmic reticu-
lum upon IP3 binding and therefore controls various
Ca2+-dependent cellular processes including fertilisation,
cell proliferation, gene expression and apoptosis [85].
IP3-mediated Ca
2+ signalling plays a role in Schwann cell
proliferation and peripheral nerve myelination [86]. Fur-
thermore, in human endothelial cells, NDRG1 interacts
with phospholipase Cc1, which mediates the production
of IP3 and diacylglycerol from PI(4,5)P2. The interaction
happens through the phosphorylation sites in the
NDRG1 C-terminal domain, but the requirement for
NDRG1 phosphorylation is unknown [87].
PI(4,5)P2 and PI(3,4,5)P3 are key players in the PI3K/
AKT/mTOR signalling pathway, in which PI3K phos-
phorylates PI(4,5)P2 to PI(3,4,5)P3, leading to AKT acti-
vation. NDRG1 has an inhibitory effect on AKT and the
expression of mTOR [88] as well as on PI3K [70], and
recently, NDRG1 was suggested to bind PI3K [89]. The
direct binding to PI(4,5)P2 and PI(3,4,5)P3 could facili-
tate NDRG1 function in this pathway. In addition
PTEN, a tumour suppressor, which antagonises the
PI3K/AKT pathway by dephosphorylating PI(3,4,5)P3
[90], upregulates expression of NDRG1 in prostate and
breast cancer cells through an AKT-dependent pathway
[36]. On the other hand, PTEN downregulation is corre-
lated with NDRG1 upregulation in endometrial carci-
noma [91]. However, NDRG1 upregulates PTEN in
pancreatic cancer cells, possibly by increasing the stabil-
ity or reducing proteasomal degradation [70], suggesting
a positive feedback loop between NDRG1 and PTEN.
Furthermore, SGK3, which binds PI3P to be directed to
endosomes downstream of the PI3K pathway [92], medi-
ates degradation of NDRG1 in breast cancer cells [93].
The PI3K/AKT/mTOR pathway has an important role
in ErbB receptor signalling in peripheral myelination as
well as in cancer metastasis [84,94]; NDRG1 has a funda-
mental role in these processes, and defects may lead to
pathological consequences.
The C-terminal region of NDRG1 is phosphorylated
in cells, which affects NDRG1 subcellular localisation
[95]. Nevertheless, the phosphorylation of NDRG1 did
not affect myelination in mice [20]. We did not study
the phosphorylated forms of NDRG1fl, and it remains
to be explored how phosphorylation affects the confor-
mation of the C-terminal region or the molecular
interactions of NDRG1.
Disease variants
NDRG1 is expressed in myelin-forming cells, and it
participates in myelin formation and maintenance
[30,62,96]. Defects in NDRG1 lead to a peripheral neu-
ropathy, CMT4D. Several human CMT4D-associated
NDRG1 mutations have been reported [4–7], and many
of them lead to a premature termination of protein
translation and truncated protein. However, two mis-
sense mutations, L146P and R234Q, were recently dis-
covered [8]. Both Leu146 and Arg234 are conserved in
all human NDRGs, as well as in all NDRG1
sequences of different species (Figs 1 and 2).
In the NDRG1 structure, Leu146 is located in the
middle of the a5 helix, its sidechain pointing towards
the central b sheet in the core of the a/b hydrolase
fold (Fig. 8C). The L146P mutation is expected to
induce a kink and disrupt the a5 helix, affecting the
hydrophobic core of the a/b hydrolase domain, leading
to unstable protein and the faster degradation of
NDRG1 reported previously [8].
Arg234 points towards the canonical catalytic site
and Asp64 and His194 in the crystal structure.
Between these residues and Arg234, there is Tyr231
which forms a p–p stacking interaction with Arg234
(Fig. 8D). The R234Q mutation leads to the loss of
this interaction, altering local electrostatics, and it
could affect the function of the putative catalytic site
as well as protein stability.
The NDRG1 sequences are highly conserved within
all mammals, including dogs (Fig. 2). The G98V muta-
tion discovered in the Alaskan Malamute causes an
inherited polyneuropathy with CMT-like symptoms
[21]. Gly98 is conserved in all species, including plants.
In the crystal structure of human NDRG1, this residue
is embedded inside the a/b hydrolase fold and induces
a sharp turn in the main chain. As a small amino acid
lacking the sidechain, Gly can form sharp turns in
polypeptide chains and take conformations not accessi-
ble to other amino acids. A mutation in Gly98 may
prevent adopting the correct main chain conformation
and affect overall folding and protein stability. These
observations suggest that Gly98 is a structurally cen-
tral residue in the NDRG family.
Concluding remarks
In conclusion, structural analyses reveal a highly
dynamic nature of NDRG1, and conformational
changes may take place in both the N- and C-terminal
regions upon interaction with a ligand, such as a metal
ion or lipid membrane (Fig. 8E). The crystal structure
of the a/b hydrolase domain provides novel informa-
tion about the canonical a/b hydrolase active site and
residues potentially involved in metal binding in
NDRG1. The structure sheds light on the likely effects
of CMT-linked NDRG1 mutations and the relationship
of NDRG1 to other members of the NDRG subfamily
of a/b hydrolases. Further studies will be required to
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elucidate the activities of the putative functional sites
and their relevance to the cellular functions of
NDRG1 as well as the molecular mechanisms of
NDRG1-linked disease.
Materials and methods
NDRG sequences were aligned with T-Coffee [97] and visu-
alised using ESPript [98]. UniProtKB accession numbers
were as follows: NDRG1 (Q92597-1), NDRG2b (Q9UN36-
2), NDRG3 (Q9UGV2-1), NDRG4 (Q9ULP0-1), dog
NDRG1 (L7V3M2-1), mouse NDRG1 (Q62433-1), zebra-
fish NDRG1 (Q6A3P5-1), fruit fly BcDNA : GH02439
(Q9Y164-1) and sunflower pollen-specific protein SF21
(Q23969-1).
Cloning, protein expression and purification
A synthetic gene encoding full-length human NDRG1
(amino acids 1–394; UniProtKB: Q92597) was purchased
from GenScript (Piscataway, NJ, USA). The cDNA was
cloned into the pET28a(+)-tobacco etch virus (TEV) vector
to produce a recombinant protein containing an N-terminal
hexahistidine tag. The expression and purification proce-
dures were identical for the full-length and truncated
NDRG1 variants. The recombinant plasmid was trans-
formed into Escherichia coli Rosetta (DE3) competent cells.
The cells were cultured in autoinducing ZYM-5052 medium
[99] supplemented with 50 lgmL1 kanamycin and
34 µgmL1 chloramphenicol for 4 h at 310.15 K and for
16 h at 293.15 K. The cells were collected by centrifugation
at 5020 g for 40 min at 277.15 K. The cell pellets were
resuspended in ice-cold buffer A (50 mM HEPES, pH 7.0,
500 mM NaCl, 10 mM imidazole pH 7.0 and 0.25 mM
TCEP pH 7.0), and half a tablet of SigmaFASTTM Protease
Inhibitor Cocktail Tablet, EDTA Free (Merck KGaA,
Darmstadt, Germany) was added to the cell suspension
prior to ultrasonication. The lysate was centrifuged at
30 600 g for 40 min at 4 °C. The supernatant was loaded
onto HisPurTM Ni-NTA Resin (Thermo Fisher Scientific
Inc., Waltham, MA, USA) pre-equilibrated with buffer A
and incubated with the resin for 2 h at 4 °C. The resin was
loaded to a column, the matrix was washed with buffer A
containing 50 mM imidazole, and the resin-bound proteins
were eluted with buffer A containing 500 mM imidazole.
The protein was desalted with buffer B (20 mM HEPES pH
7.0, 200 mM NaCl and 0.25 mM TCEP pH 7.0) using a
PD-10 Desalting Column with Sephadex G-25 Resin (GE
Healthcare, Chicago, IL, USA). The hexahistidine tag was
cleaved by incubation with His-tagged TEV protease at
303.15 K for 2 h, followed by Ni-NTA column chromatog-
raphy using buffer B containing 50 mM imidazole. The
eluted proteins were filtered using an Ultrafree-CL Cen-
trifugal Filter (0.22 µm, Merck KGaA) and loaded onto a
HiLoad 16/60 Superdex 75 column (GE Healthcare) equili-
brated with buffer B. The purified protein was concentrated
using a Vivaspin Turbo 4 Ultrafiltration Unit (Sartorius,
G€ottingen, Germany) for further studies.
Mutagenesis of truncated NDRG1 proteins
A vector containing C-terminally truncated NDRG1
(amino acids 1–319, NDRG11–319) was produced from the
NDRG1fl-pET28aTEV plasmid by PCR using Phusion
High-Fidelity DNA Polymerase (Thermo Fisher Scientific
Inc.). The PCR products were digested with DpnI, purified
using NucleoSpin Gel and PCR Clean-up kit (Macherey-
Nagel, D€uren, Germany) and transformed to Top10 cells.
The recombinant vector was produced and isolated as for
the full-length NDRG1 described above.
A vector containing the N-terminally truncated NDRG1
(NDRG128–319, NDRG131–319 or NDRG131–394) was
produced by PCR from the plasmid containing the
NDRG11–319 or NDRG1fl, respectively, the PCR products
were digested with DpnI, and DNA was extracted from a
0.8% agarose gel using the NucleoSpin Gel and PCR
Clean-up kit (Macherey-Nagel). Plasmid DNA was ligated
with T4 DNA ligase and transformed to Top10 cells. Colo-
nies were screened by PCR using Taq polymerase and cul-
tured in LB medium supplemented with 50 lgmL1
kanamycin, and the recombinant vector was isolated as for
the full-length NDRG1 described above.
Multiangle light scattering
SEC-MALS was used to determine the monodispersity and
molecular weight of NDRG1 in solution. Chromatography
was performed using a Shimadzu HPLC Unit and a Super-
dex 75 Increase 10/300 (GE Healthcare) column with
20 mM HEPES (pH 7.0), 200 mM NaCl, 0.25 mM TCEP
(pH 7.5) as mobile phase. One hundred-microgram samples
were injected into the column at an isocratic flow of
0.5 mLmin1, and light scattering was recorded using a
Wyatt miniDAWN TREOS instrument (Wyatt Technology,
Santa Barbara, CA, USA). Protein concentration was
determined using a Shimadzu refractometer. Data were
analysed using the ASTRA software (Wyatt Technology).
Crystallisation
NDRG131–319 was concentrated to 17.2 mgmL1, and initial
crystallisation was performed with commercial screening kits
(Molecular Dimensions, Maumee, OH, USA) using the sit-
ting drop vapour-diffusion method at 20 °C. First crystals
were produced using 1.4 M sodium malonate (pH 6.0). The
crystals were further optimised with a screen containing 1.3–
1.6 M sodium malonate (pH 5.75–6.50) and 5–15 mM TCEP
(pH 7.0). The best crystals were grown at 285.15 K in drops
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containing 200–300 nL of 16.6 mgmL1 protein and 300–
400 nL of crystallisation solution containing 1.4 M sodium
malonate (pH 6.25), 10 mM TCEP (pH 7.0). Crystals were
cryoprotected with 1.8 M sodium malonate (pH 6.25) and
flash-frozen in liquid nitrogen prior to data collection.
Data collection, refinement and structural
determination
X-ray diffraction data were collected at the PETRA III
(DESY, Hamburg, Germany) synchrotron, on beamline
P11 [100] at 100 K. The X-ray diffraction data were pro-
cessed and scaled using XDS [101]. The crystals belonged
to the space group P43212 with two molecules in the asym-
metric unit. The structure was solved using molecular
replacement with the structure of human NDRG2 (PDB
ID: 2XMQ) [26] as a search model using Phaser-MR [102]
in the PHENIX software [103]. The model was completed
by iterative cycles of refinement using phenix.refine [104]
and WinCoot [105]. The coordinates and structure factors
were deposited to the PDB (PDB ID: 6ZMM).
Small-angle X-ray scattering
SEC-SAXS data were collected from samples at 5–
14 mgmL1 at the Diamond Light Source (Didcot, UK) on
beamline B21 and at SOLEIL (Saint Aubin, Essonne, France)
on beamline SWING. SEC was performed using a Superdex
200 (GE Healthcare) or a BioSEC3-300 (Agilent Technolo-
gies, Santa Clara, CA, USA) column with buffer containing
20–50 mM HEPES (pH 7.0), 100–200 mM NaCl, 0.25 mM
TCEP (pH 7.0). Data were processed and analysed using Fox-
trot (SOLEIL) and ScAtter (http://www.bioisis.net/tutorials/
9), and model building was done with GASBOR [106] and
EOM [68] from the ATSAS package [107].
Lipid vesicle preparation
Phosphatidylinositol phosphates were purchased from Ech-
elon Biosciences (Salt Lake City, UT, USA). POPC,
DMPC and DMPG were purchased from Avanti Polar
Lipids (Alabaster, AL, USA) and Anatrace (Maumee, OH,
USA). Lipid stocks were prepared by dissolving dry lipids
in chloroform : methanol : water (20 : 13 : 3 v/v). All mix-
tures were prepared from stocks at the desired molar ratios
and dried under a stream of air. The dried lipids were
resuspended in water, and the suspensions were clarified
using Branson 450 Digital Sonifier (Marshall Scientific
LLC, Hampton, NH, USA).
Circular dichroism spectroscopy
CD spectra were measured from 1.0 µM protein samples in
10 mM HEPES (pH 7.0), 100 mM NaF, 0.10 mM TCEP
(pH 7.5), using quartz cuvettes with a 1.0-mm pathlength
and a Chirascan CD Spectrometer (Applied Photophysics
Ltd, Leatherhead, Surrey, UK). 100 µM of lipid vesicles or
5–50 µM of metallic salts was mixed with the protein prior
to the measurement. Spectra were recorded twice for each
sample from 198 to 280 nm at 25 °C. Buffer spectra were
subtracted, and the sample spectra were averaged.
Synchrotron radiation circular dichroism data were col-
lected from 0.5 mgmL1 protein samples in 20 mM HEPES
(pH 7.0), 150 mM NaF, 0.25 mM TCEP (pH 7.0) on the
AU-CD beamline at the ASTRID2 synchrotron (ISA, Aar-
hus, Denmark). 1.43 mM lipid vesicles were mixed with the
protein (P/L ratio 1 : 100) prior to measurement. Hellma
cylindrical absorption cuvette (Suprasil quartz, Hellma
GmbH & Co. KG, M€ullheim, Germany) with a pathlength
of 100 lm was used for the measurements. Spectra were
recorded three times for each sample from 170 to 280 nm
at 25 °C. Buffer spectra were subtracted, and the sample
spectra were processed and averaged using CDtoolX [108].
Secondary structure deconvolutions were done with K2D3
[109].
Lipid cosedimentation assay
One millimolar of lipid vesicles was mixed with 10 µM pro-
tein in 20 mM HEPES (pH 7.0) and 150 mM NaCl, and
samples of 50 µL were incubated for 1 h at room tempera-
ture. Vesicles and bound proteins were sedimented by 1 h
of ultracentrifugation at 434 500 g at 288.15 K using an
Optima TL ultracentrifuge and a TLA-100 rotor (Beckman
Coulter, Indianapolis, IN, USA). The pellets were resus-
pended, and both the soluble and sedimented fractions
were analysed on SDS-PAGE. Fifty micromolar NiSO4
was mixed with 10 µM protein and 1 mM POPC to see
whether nickel affects POPC binding. The lipid cosedimen-
tation assays were performed three times with each vesicle
composition and protein construct. Gel bands were quanti-
fied using IMAGEJ [110].
Protein stability analysis
Nano-DSF was used to study the stability of the different
protein constructs and the effect of metals on the stability
of NDRG1. Nano-DSF data were collected from 5 µM pro-
tein samples with 50 µM metallic salts in 20 mM HEPES
(pH 7.0) and 150 mM NaCl using Prometheus NT.48
(NanoTemper Technologies GmbH, M€unchen, Germany).
Isothermal titration calorimetry
The proteins were dialysed into 20 mM HEPES (pH 7.0),
100 mM NaCl, 0.10 mM TCEP (pH 7.5) and diluted to
30 µM. In total, 38.65 µL of 360 µM NiSO4 was titrated
into 280 µL of protein using a MicroCal iTC 200
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calorimeter (GE Healthcare). All samples were prepared
and measured twice. Data were analysed with ORIGIN (Ori-
ginLab Corporation, Northampton, MA, USA).
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